40 results
Page 2 of 2
10-K
s8clq
1 Mar 21
Annual report
12:00am
10-K
EX-10.22
ean67 5r43vp
1 Mar 21
Annual report
12:00am
6-K
EX-99.1
gmmmojzg 6cf
29 Dec 20
Zai Lab Announces Inclusion of ZEJULA® (Niraparib) in China’s National Reimbursement Drug List
7:30am
6-K
EX-1.1
38syu7fh97t5
21 Sep 20
Current report (foreign)
4:15pm
6-K
EX-99.1
zteq8gaiwi7qpzyyu
11 Sep 20
Zai Lab Limited Supplemental and Updated Disclosures
8:09am
424B2
e7jdymphkzb8
24 Jan 20
Prospectus for primary offering
7:24am
6-K
EX-1.1
a0m7ik8h hm1k
22 Jan 20
Current report (foreign)
11:58am
424B5
3600u
21 Jan 20
Prospectus supplement for primary offering
5:31pm
20-F/A
EX-10.15
5np78me
23 Aug 19
Annual report (foreign) (amended)
5:00pm
20-F/A
EX-10.15
wnceaz 22
26 Jun 19
Annual report (foreign) (amended)
6:07am
6-K
EX-1.1
jyv2mjyhy d2vj9ca
2 May 19
Current report (foreign)
11:39am
6-K
EX-99.1
qkvctlc
12 Dec 18
Zai Lab Announces Acceptance of NDA Submission of ZEJULA (Niraparib) in Mainland China by the NMPA
7:35am
424B4
s0zhrp oj
7 Sep 18
Prospectus supplement with pricing info
12:00am
20-F
EX-4.11
1rn4x8m64l
30 Apr 18
Annual report (foreign)
9:07am
20-F
kag79 p3tm98wyrd
30 Apr 18
Annual report (foreign)
9:07am